Eurofins Biomnis Develops Cereulide Toxin Detection Method for Stool Samples
Event summary
- Eurofins Biomnis launched a new LC-MS/MS method for detecting cereulide toxin in stool samples on March 11, 2026.
- The method is validated for human stool samples, meeting ISO 15189 requirements except for inter-method comparison on pathological clinical samples.
- Cereulide toxin, produced by Bacillus cereus, has gained attention due to recent contamination events involving infant formula.
- The French Society of Pediatrics recommended reliable analytical tools for clinical investigations in February 2026.
The big picture
Eurofins Biomnis' new method addresses a critical gap in detecting cereulide toxin, a growing concern in foodborne intoxication cases. The development aligns with increasing regulatory focus on food safety and clinical diagnostics, particularly in vulnerable populations. This innovation could enhance Eurofins Biomnis' competitive edge in the specialized clinical diagnostics market, which is valued at billions globally.
What we're watching
- Adoption Pace
- How quickly Eurofins Biomnis can integrate this method into routine medical biology practice.
- Regulatory Impact
- Whether the French Society of Pediatrics' recommendations will drive broader adoption of this method.
- Market Differentiation
- The extent to which this method can position Eurofins Biomnis as a leader in specialized clinical diagnostics.
Related topics